Inside the Practice: Inside Pafolacianine

Phillip Low, PhD, Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry-Biochemistry from Purdue University joined Inside the Practice to discuss the creation and approval of pafolacianine. This agent was approved in November 2021 to be utilized during surgery to identify malignant ovarian lesions. In the interview, Low discusses how the idea came to be, implementing this as a standard of practice, and the potential to utilize this agent for other cancers.